162 related articles for article (PubMed ID: 11045792)
21. Breast cancer recurrences in elderly patients after lumpectomy.
Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND
Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment.
Veronesi A; Pizzichetta MA; Ferlante MA; Zottar M; Magri MD; Crivellari D; Foladore S
Tumori; 1998; 84(3):372-5. PubMed ID: 9678620
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen hits the target in situ.
Wilcken NR
Lancet; 1999 Jun; 353(9169):1986-7. PubMed ID: 10376607
[No Abstract] [Full Text] [Related]
24. A review of breast cancer chemoprevention.
Chang JC
Biomed Pharmacother; 1998; 52(3):133-6. PubMed ID: 9755806
[TBL] [Abstract][Full Text] [Related]
25. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
26. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.
Boland GP; McKeown A; Chan KC; Prasad R; Knox WF; Bundred NJ
Br J Cancer; 2003 Jul; 89(2):277-83. PubMed ID: 12865917
[TBL] [Abstract][Full Text] [Related]
27. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
[TBL] [Abstract][Full Text] [Related]
28. Acceptance and adherence to chemoprevention among women at increased risk of breast cancer.
Roetzheim RG; Lee JH; Fulp W; Matos Gomez E; Clayton E; Tollin S; Khakpour N; Laronga C; Lee MC; Kiluk JV
Breast; 2015 Feb; 24(1):51-6. PubMed ID: 25491191
[TBL] [Abstract][Full Text] [Related]
29. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
30. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
Rouanet P; Linares-Cruz G; Dravet F; Poujol S; Gourgou S; Simony-Lafontaine J; Grenier J; Kramar A; Girault J; Le Nestour E; Maudelonde T
J Clin Oncol; 2005 May; 23(13):2980-7. PubMed ID: 15860853
[TBL] [Abstract][Full Text] [Related]
32. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
Trunet P; Marty M
Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
[TBL] [Abstract][Full Text] [Related]
33. Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy.
Atwell LL; Zhang Z; Mori M; Farris P; Vetto JT; Naik AM; Oh KY; Thuillier P; Ho E; Shannon J
Cancer Prev Res (Phila); 2015 Dec; 8(12):1184-1191. PubMed ID: 26511489
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
35. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Wolmark N
Clin Breast Cancer; 2002 Jun; 3(2):153-9. PubMed ID: 12123540
[TBL] [Abstract][Full Text] [Related]
36. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
Vogel VG; Costantino JP; Wickerham DL; Cronin WM
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer treatment and chemoprevention.
Kotwall CA
Can Fam Physician; 1999 Aug; 45():1917-24. PubMed ID: 10463092
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation.
Verkooijen HM;
Int J Cancer; 2002 Jun; 99(6):853-9. PubMed ID: 12115488
[TBL] [Abstract][Full Text] [Related]
39. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
Powles T; Eeles R; Ashley S; Easton D; Chang J; Dowsett M; Tidy A; Viggers J; Davey J
Lancet; 1998 Jul; 352(9122):98-101. PubMed ID: 9672274
[TBL] [Abstract][Full Text] [Related]
40. Chemoprevention of breast cancer.
Castrellon AB; Glück S
Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
